The drug failed as a treatment for hepatitis and Ebola. With federal funding, scientists trained it on the coronavirus.
from Health https://ift.tt/35oleik
May 01, 2020
Rose
Health, Health - The New York Times
No comments
Related Posts:
Gut Healing Is TikTok’s Latest Trend. Does It Work?Despite what social media might have you believe, there is no overnight shortcut to better digestive health. from NYT > Health https://ift.tt/xeEvU4N … Read More
Moderna Says Trial Suggests Redesigned Vaccines Protect Against VariantsResearchers combined Moderna’s existing vaccine with one designed to attack the Beta variant, and found it provided a stronger defense against several variants. from NYT > Health https://ift.tt/S5gQX7n … Read More
Americans Over 60 Should Get Second Booster, Official SaysCiting data from Israel, the Biden administration’s Covid response coordinator, said a second booster offered significant protection to older people. from NYT > Health https://ift.tt/xs0Qctk … Read More
Scientists Question Data Behind an Experimental Alzheimer’s DrugStudies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals. from NYT > Health https://ift.tt/pWQn3iV … Read More
Study Raises Questions About Popular Genetic Test for ‘Abnormal’ EmbryosThe test leads people undergoing in vitro fertilization to discard thousands of embryos each year. The new research found implanting some “abnormal” embryos resulted in healthy live births. from NYT > Health https://ift.t… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment